Abstract Details
| Fredric J. Cohen, MD (Strongbridge Biopharma) | No disclosure on file |
| Raed Alroughani, MD, FAAN | Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi. |
| No disclosure on file |